MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
attributable to common...
-$105,614K
Net loss
-$105,609K
Unrealized (loss) gain on
available-for-sale securities
-$5K
Other income, net
$1,236K
Loss from operations
-$102,266K
Sermonix pre-funded
warrant change in fair...
$4,579K
Total operating
expenses
$102,266K
Acquired in-process
research and development
$68,088K
Research and development
$17,500K
General and
administrative
$16,678K
Back
Back
Income Statement
source: myfinsight.com
LeonaBio, Inc. (LONA)
LeonaBio, Inc. (LONA)